Home > Services > Pulmonology and Respiratory Medicine > Programs > Interstitial Lung Disease
Pulmonology and Respiratory Medicine
Ranked among the top 10 pulmonary programs by U.S.News & World Report

Interstitial Lung Disease

Interstitial lung diseases (ILDs) are a group of non-cancerous disorders characterized by widespread inflammation and scarring of the lung. Patients typically experience coughing and shortness of breath.

A recognized leader in the care of ILD patients, Duke’s Interstitial Lung Disease Program sees hundreds of newly referred patients every year.

Our Pulmonary, Allergy, and Critical Care Medicine specialists comprehensively evaluate, diagnose, and treat patients suffering from ILDs that include:

  • Idiopathic pulmonary fibrosis (IPF)
  • Sarcoidosis
  • Pulmonary vasculitis
  • Hypersensitivity pneumonitis
  • Asbestosis

We also serve patients with pulmonary conditions caused by rheumatic and autoimmune disorders such as lupus, rheumatoid arthritis, and scleroderma.

In an effort to develop more effective ways of diagnosing and treating these conditions, Duke maintains an active research program that continues to make strides in understanding ILDs on a cellular level. Our ILD patients have the opportunity to participate in a number of clinical drug trials.

To learn more about the services Duke Medicine provides to patients with interstitial lung diseases, or to schedule an appointment or get a referral, call 919-668-7630 locally or 888-ASK-DUKE (888-275-3853) toll-free.

Physicians

Physicians offering this service include:

Locations

This service is available at: